Ticker,Title,Link
IMRX,Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference,8/29/2024 2:00:00 PM
IMRX,"Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Immuneering (IMRX) and Vera Therapeutics (VERA)",8/9/2024 1:38:09 PM
IMRX,Immuneering reports Q2 results,8/7/2024 5:14:57 PM
IMRX,Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates,8/6/2024 10:05:00 PM
IMRX,"Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), Eli Lilly & Co (LLY) and Teva Pharmaceutical (TEVA)",8/5/2024 7:40:51 AM
IMRX,Why is Immuneering (IMRX) Stock Up 24% Today?,8/1/2024 7:36:31 PM
IMRX,Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic Cancer,7/31/2024 10:05:00 PM
IMRX,Immuneering to Present at the Jefferies Global Healthcare Conference,5/29/2024 10:05:00 PM
IMRX,Buy Rating Affirmed for Immuneering with $8 Price Target Amidst Promising Pipeline and Upcoming Data Events,5/16/2024 8:35:48 AM
IMRX,Oppenheimer Keeps Their Buy Rating on Immuneering (IMRX),5/13/2024 11:55:52 AM
IMRX,Immuneering reports Q1 results,5/8/2024 2:50:01 PM
IMRX,Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates,5/7/2024 10:05:00 PM
IMRX,Immuneering Recognizes Melanoma Awareness Month,5/6/2024 10:30:00 PM
IMRX,Buy Rating Affirmed: Immuneering’s Lead Asset IMM-1-104 Shows Promise Despite Market Skepticism,5/2/2024 7:25:24 AM
IMRX,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Enlivex (ENLV), MacroGenics (MGNX) and Immuneering (IMRX)",4/12/2024 10:30:35 AM
IMRX,IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models,4/9/2024 6:00:00 PM
IMRX,Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference,4/3/2024 10:05:00 PM
IMRX,Buy Rating Affirmed for Immuneering on Solid Trial Progress and Insider Confidence,3/29/2024 8:26:11 AM
IMRX,Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations,3/27/2024 1:00:00 PM
IMRX,"STEM, SOUN and GRFS among pre-market losers",3/22/2024 12:23:55 PM
IMRX,"Analysts Are Bullish on These Healthcare Stocks: Immuneering (IMRX), Structure Therapeutics, Inc. Sponsored ADR (GPCR)",3/19/2024 5:40:25 AM
IMRX,"MDGL, MAXN and DLO are among after hour movers",3/18/2024 8:38:49 PM
IMRX,"Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data",3/15/2024 8:29:25 PM
IMRX,"AUR, CDLX and PTGX are among after hour movers",3/14/2024 9:02:13 PM
IMRX,"Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors",3/12/2024 1:00:00 PM
IMRX,Immuneering’s IMM-1-104 Progress Garners Buy Rating Amid Favorable Phase 2 Dose Determination and Anticipated Phase 1 Data,3/11/2024 2:05:37 PM
IMRX,Immuneering to Present Preclinical Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2024,3/5/2024 11:00:00 PM
IMRX,Immuneering to Participate in the Cowen 44th Annual Health Care Conference,3/4/2024 2:00:00 PM
IMRX,Promising Clinical and Regulatory Milestones for Immuneering’s Lead MAPK Inhibitor Program Propel Buy Rating,3/1/2024 6:16:40 PM
IMRX,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Immuneering (IMRX), Halozyme (HALO) and Repligen (RGEN)",2/26/2024 5:10:23 AM
IMRX,Immuneering Gets Fast-Track Designation For IMM-1-104 In Pancreatic Cancer ,2/20/2024 4:04:23 PM
IMRX,3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave,2/14/2024 8:45:00 PM
IMRX,Immuneering Announces Participation in February Investor Conferences ,2/1/2024 2:00:00 PM
IMRX,Immuneering’s Growth Prospects Bolstered by IND Clearance and Positive Clinical Developments: A Strong Buy Recommendation,12/15/2023 7:47:19 AM
IMRX,Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations,12/12/2023 2:00:00 PM
IMRX,"3 Best Stocks to Buy Now, 6/12/2023, According to Top Analysts ",12/6/2023 8:37:10 AM
IMRX,Oppenheimer Keeps Their Buy Rating on Immuneering (IMRX),12/5/2023 12:55:38 PM
IMRX,Buy Rating Affirmed for Immuneering on Clinical Progress and Strong Market Potential,12/1/2023 10:55:37 AM
IMRX,Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference,11/20/2023 10:05:00 PM
IMRX,Piper Sandler Keeps Their Buy Rating on Immuneering (IMRX),11/13/2023 12:19:23 PM
IMRX,Promising Clinical Trials and Strong Financial Position: Buy Rating on Immuneering’s Stock (IMRX),11/10/2023 4:27:39 PM
IMRX,Immuneering Reports Third Quarter 2023 Financial Results and Provides Business Updates,11/9/2023 10:05:00 PM
IMRX,"Analysts’ Top Healthcare Picks: Immuneering (IMRX), PepGen Inc. (PEPG)",10/17/2023 5:20:07 AM
IMRX,Immuneering Presents Preclinical Data Demonstrating Encouraging Anti-Tumor Activity for IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC Conference,10/12/2023 10:05:00 PM
IMRX,Immuneering to Present Preclinical Data on IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,10/4/2023 10:05:00 PM
IMRX,Immuneering to Present at the Morgan Stanley Healthcare Conference,9/6/2023 2:00:00 PM
IMRX,4 Analysts Have This to Say About Immuneering,8/8/2023 10:00:26 PM
IMRX,Chardan Capital Reaffirms Their Buy Rating on Immuneering (IMRX),8/7/2023 9:45:13 AM
IMRX,Mizuho Securities Keeps Their Buy Rating on Immuneering (IMRX),8/4/2023 2:55:05 AM
IMRX,Immuneering GAAP EPS of -$0.43 beats by $0.08,8/3/2023 10:01:05 PM
IMRX,Expert Ratings for Immuneering,6/26/2023 2:02:42 PM
IMRX,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galapagos (GLPG), BioNTech SE (BNTX) and Immuneering (IMRX)",6/5/2023 1:10:07 PM
IMRX,"Analysts Offer Insights on Healthcare Companies: IVERIC bio (ISEE), Sensus Healthcare (SRTS) and Immuneering (IMRX)",5/5/2023 11:50:12 AM
IMRX,Mizuho Securities Sticks to Its Buy Rating for Immuneering (IMRX),5/4/2023 10:35:05 PM
IMRX,Analyst Doubles Immuneering Price Target Citing Initial Data Validation,4/19/2023 7:50:22 PM
IMRX,"Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023",3/30/2023 5:00:39 PM
IMRX,Immuneering (IMRX) Receives a New Rating from Mizuho Securities,3/29/2023 8:15:08 PM
IMRX,"Pre-market Movers: VKTX, IMRX, OSCR, WISA, ITCI… ",3/28/2023 2:21:58 PM
IMRX,Top 5 Health Care Stocks That Are Ticking Portfolio Bombs,3/14/2023 1:45:47 PM
IMRX,"Ocean Biomedical, Avenue top healthcare gainers; InVivo, Akebia lead losers' pack",3/9/2023 3:01:05 PM
IMRX,"AVAH, IMRX and SFR among mid-day movers",3/8/2023 5:54:43 PM
IMRX,Analysts Offer Insights on Healthcare Companies: Penumbra (PEN) and Immuneering (IMRX),3/7/2023 1:01:36 PM
IMRX,Immuneering GAAP EPS of -$0.50 beats by $0.08,3/6/2023 10:19:53 PM
IMRX,Immuneering A is about to announce its earnings — here's what to expect,3/5/2023 3:01:13 PM
IMRX,Immuneering slips as Morgan Stanley downgrades on lack of catalysts,2/3/2023 7:36:15 PM
IMRX,"FUTU, TIGR and PALI among mid-day gainers and losers",12/30/2022 5:43:29 PM
IMRX,"BRY, CRCT and IMRX are among after hour movers",11/16/2022 11:06:24 PM
IMRX,Immuneering (IMRX) Receives a New Rating from Chardan Capital,11/11/2022 10:35:08 AM
IMRX,Immuneering Presents Promising Preclinical Data on its Second Program IMM-6-415 at the 37th Annual Meeting of SITC,11/10/2022 3:00:00 PM
IMRX,Immuneering Announces Participation in November Investor Conferences,11/3/2022 11:50:00 AM
IMRX,Immuneering Appoints Leah R. Neufeld as Chief People Officer,10/20/2022 12:50:00 PM
IMRX,Immuneering To Present Poster on IMM-6-415 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC),10/5/2022 2:05:00 PM
IMRX,Why F45 Training  Shares Climbed 41%; Here Are 84 Biggest Movers From Friday,10/3/2022 9:25:16 AM
IMRX,"Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session",9/30/2022 6:06:41 PM
IMRX,Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday,9/23/2022 9:42:11 AM
IMRX,Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday,9/14/2022 9:58:12 AM
IMRX,Immuneering slides on CFO's exit,9/7/2022 12:23:24 PM
IMRX,Immuneering Submits IND Application To FDA For Phase 1/2a Trial Of IMM-1-104 On Solid Tumors ,9/2/2022 2:59:33 PM
IMRX,Immuneering Announces Participation in September Investor Conferences,8/25/2022 12:50:00 PM
IMRX,Immuneering Reports Second Quarter 2022 Financial Results and Recent Business Highlights ,8/10/2022 10:05:00 PM
IMRX,"Tesla, Twitter And 76 Biggest Movers From Friday",7/11/2022 1:30:29 PM
IMRX,Why This Small-Cap Stock Is Gaining More Than 10% Today?,7/8/2022 5:40:32 PM
IMRX,Immuneering Announces Participation in William Blair Biotech Focus Conference 2022,7/6/2022 12:50:00 PM
IMRX,91 Biggest Movers From Friday,6/13/2022 10:28:39 AM
IMRX,Morgan Stanley updates biotechs with negative enterprise values & 2022 catalysts,5/31/2022 1:06:50 AM
IMRX,Immuneering Reports Data in Two Preclinical Abstracts at the ASCO 2022 Annual Meeting Highlighting Pan-KRAS/NRAS Activity of IMM-1-104,5/26/2022 11:26:00 PM
IMRX,Immuneering Announces Participation in Upcoming Investor Conferences,5/20/2022 12:50:00 PM
IMRX,Immuneering Reports First Quarter 2022 Financial Results and Recent Business Highlights ,5/10/2022 12:30:00 PM
IMRX,Immuneering Announces Participation in Citi’s Biopharma VIRTUAL Co-Panel Day,5/5/2022 12:50:00 PM
IMRX,"PDD, CORZ and FCUV among after hour movers",4/14/2022 8:54:56 PM
IMRX,55 Biggest Movers From Friday,4/4/2022 10:59:20 AM
IMRX,"Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022",4/1/2022 4:17:30 PM
IMRX,"AOUT, IMRX and AMRN among after hour movers",3/31/2022 10:13:47 PM
IMRX,Immuneering Announces Participation in the 21st Annual Needham Virtual Healthcare Conference,3/24/2022 11:55:00 AM
IMRX,Immuneering Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates,3/10/2022 12:30:00 PM
IMRX,Immuneering Announces Participation in March Investor Conferences,2/24/2022 12:50:00 PM
IMRX,Immuneering Announces Participation in Upcoming Investor Conferences,1/24/2022 12:50:00 PM
IMRX,"Catalyst watch for next week: Earnings blitz headlined by Apple, Microsoft, Boeing and Tesla",1/21/2022 8:00:18 PM
IMRX,"Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.",1/18/2022 12:50:00 PM
IMRX,"Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022",1/7/2022 4:38:12 PM
IMRX,Immuneering Reports Compelling Preclinical Data on IMM-1-104 in NRAS Mutant Melanoma Model And Will Host Key External Expert Investor Event,1/6/2022 10:10:00 PM
IMRX,"Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice President, Project and Alliance Management",1/3/2022 12:50:00 PM
IMRX,12 Healthcare Stocks That Trade At Premium To Their IPO Price ,12/28/2021 10:48:20 AM
IMRX,Immuneering Added to the Nasdaq Biotechnology Index,12/16/2021 12:50:00 PM
IMRX,Immuneering Announces Participation in December Investor Conferences,11/18/2021 12:35:00 PM
IMRX,Immuneering to Participate in Jefferies 2021 London Healthcare Conference,11/10/2021 12:50:00 PM
IMRX,"Immuneering EPS beats by $0.05, beats on revenue",11/9/2021 1:57:53 PM
IMRX,46 Biggest Movers From Yesterday,10/12/2021 11:01:24 AM
IMRX,Immuneering Reports Compelling Preclinical Data on IMM-1-104 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,10/11/2021 12:50:00 PM
IMRX,Immuneering to Present Key Preclinical Data Across Several Poster Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,10/1/2021 12:50:00 PM
IMRX,50 Biggest Movers From Yesterday,9/28/2021 11:07:42 AM
IMRX,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",9/21/2021 2:20:50 PM
IMRX,Immuneering Announces Inclusion in the Russell 2000® Index,9/20/2021 10:10:00 PM
IMRX,60 Biggest Movers From Friday,9/13/2021 11:07:11 AM
IMRX,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",9/9/2021 2:17:07 PM
IMRX,Immuneering to Participate in September Investor Conferences,9/2/2021 10:05:00 PM
IMRX,"Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021",8/24/2021 4:03:36 PM
IMRX,"The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More",8/22/2021 3:01:25 PM
IMRX,"The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO",8/6/2021 1:42:39 PM
IMRX,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",8/5/2021 2:07:56 PM
IMRX,58 Stocks Moving In Wednesday's Mid-Day Session,8/4/2021 6:09:35 PM
IMRX,Immuneering Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares,8/3/2021 10:07:00 PM
IMRX,63 Biggest Movers From Friday,8/2/2021 11:13:12 AM
IMRX,"The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs",7/30/2021 1:53:58 PM
